Related content

Erlotinib in the first-line treatment of non-small-cell lung cancer

By D'Arcangelo Manolo   Cappuzzo Federico  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 523-533

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy: still an essential player in non-small-cell lung cancer treatment?

By Ferreira Carlos Gil   Montella Tatiane Caldas   Baldotto Clarissa Seródio   Domingues Pedro Masson  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 381-390

Future Medicine

Access to resources Recommend Favorite

New oral multitargeted antiangiogenics in non-small-cell lung cancer treatment

By Gori Bruno   Ricciardi Serena   Fulvi Alberto   Del Signore Ester   de Marinis Filippo  

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 559-573

Future Medicine

Access to resources Recommend Favorite

Role of bevacizumab for the treatment of non-small-cell lung cancer

By Ramalingam Suresh   Belani Chandra P  

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 131-139

Future Medicine

Access to resources Recommend Favorite

Ethnic differences in non-small-cell lung cancer treatment: the Asian perspective

By Ahn Myung-Ju   Sun Jong-Mu   Ahn Jin Seok   Park Keunchil  

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 309-315

Future Medicine

Access to resources Recommend Favorite